Latest news
AstraZeneca (AZN) And Bristol Myers Squibb (BMY) Deny Any Merger Discussions Following Major Investor Backlash - londoninsider.co.uklondoninsider.co.uk · Sun, 09 Aug 2026 02:00:03 GMTFDA approves first-in-class drug to treat narcolepsy - Drug Discovery NewsDrug Discovery News · Fri, 07 Aug 2026 19:48:16 GMTYour Questions Answered: The Biggest Pharma Stories of the Week of August 3-7, 2026 - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 07 Aug 2026 10:07:38 GMTAstraZeneca (AZN) And Bristol Myers Squibb (BMY) Merger Speculation Denied As Drone Delivery And AI Reshape Pharma Supply Chain - londoninsider.co.uklondoninsider.co.uk · Fri, 07 Aug 2026 05:24:21 GMTACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial - Applied Clinical Trials OnlineApplied Clinical Trials Online · Thu, 06 Aug 2026 13:54:48 GMTPharma Pulse: AstraZeneca-BMS Speculation Cools, Drones Land in Pharmacy, Agentic AI Hits 3PL - Pharmaceutical CommercePharmaceutical Commerce · Thu, 06 Aug 2026 13:01:55 GMTAstraZeneca may buck a decade of pharma strategy to buy U.S. scale - CNBCCNBC · Thu, 06 Aug 2026 09:40:16 GMTAstraZeneca denies media report of merger talks with BMS - medwatch.commedwatch.com · Thu, 06 Aug 2026 06:19:32 GMT